CRIS Current Research Information System

TRAZZI, STEFANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.670
NA - Nord America 3.366
EU - Europa 2.838
AF - Africa 350
SA - Sud America 144
OC - Oceania 5
Totale 10.373
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.319
IT - Italia 1.194
VN - Vietnam 1.160
SG - Singapore 977
CN - Cina 785
GB - Regno Unito 397
DE - Germania 319
HK - Hong Kong 295
SE - Svezia 166
NL - Olanda 150
IN - India 126
FR - Francia 107
IE - Irlanda 105
BR - Brasile 102
TG - Togo 90
SC - Seychelles 89
KR - Corea 83
CI - Costa d'Avorio 75
RU - Federazione Russa 75
FI - Finlandia 55
ZA - Sudafrica 50
JP - Giappone 45
ES - Italia 42
BG - Bulgaria 41
JO - Giordania 36
CH - Svizzera 32
CA - Canada 30
PH - Filippine 29
ID - Indonesia 26
AT - Austria 25
NG - Nigeria 25
UA - Ucraina 25
AR - Argentina 22
EE - Estonia 21
TR - Turchia 21
BE - Belgio 18
TH - Thailandia 18
BD - Bangladesh 16
PL - Polonia 14
MX - Messico 10
TW - Taiwan 9
DK - Danimarca 8
HR - Croazia 8
MY - Malesia 7
PK - Pakistan 7
RO - Romania 7
AE - Emirati Arabi Uniti 6
GR - Grecia 6
MA - Marocco 6
AU - Australia 5
IQ - Iraq 5
IR - Iran 5
SM - San Marino 5
VE - Venezuela 5
CZ - Repubblica Ceca 4
LB - Libano 4
PE - Perù 4
CL - Cile 3
CO - Colombia 3
DZ - Algeria 3
EG - Egitto 3
PT - Portogallo 3
SA - Arabia Saudita 3
TN - Tunisia 3
EC - Ecuador 2
MD - Moldavia 2
NO - Norvegia 2
NP - Nepal 2
PY - Paraguay 2
TT - Trinidad e Tobago 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GH - Ghana 1
GI - Gibilterra 1
HN - Honduras 1
IS - Islanda 1
KE - Kenya 1
LK - Sri Lanka 1
LV - Lettonia 1
MU - Mauritius 1
NI - Nicaragua 1
PA - Panama 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 10.373
Salva come PNG Salva come JPEG
Città #
Singapore 731
Bologna 457
Ashburn 402
Chandler 337
Ho Chi Minh City 302
Fairfield 290
Hong Kong 259
Southend 255
Hanoi 247
Hefei 175
San Jose 152
Houston 148
Santa Clara 144
Woodbridge 131
Wilmington 129
Dong Ket 128
Seattle 127
Ann Arbor 110
Dublin 104
Beijing 96
Lomé 90
Cambridge 87
Dallas 82
Abidjan 75
Seoul 75
Princeton 72
Boardman 67
Los Angeles 60
Frankfurt am Main 58
Council Bluffs 57
Turin 57
Bristol 55
Milan 43
Helsinki 41
New York 41
Sofia 39
Lauterbourg 37
Amman 36
Falls Church 34
Redmond 34
Rome 32
Tokyo 32
Trento 31
Islington 29
Buffalo 28
Haiphong 28
Westminster 28
Marano 27
Nanjing 27
Berlin 26
Da Nang 26
Munich 26
Bern 25
Padova 25
Amsterdam 23
Argelato 21
Johannesburg 21
San Diego 21
Abeokuta 20
Orem 20
Bremen 19
Rimini 19
Vienna 18
Bengaluru 17
Brussels 17
Bonn 15
Guangzhou 15
Hebei 15
Jerez De La Frontera 15
Redondo Beach 15
Biên Hòa 14
Bolzano 14
Castel Maggiore 14
Changsha 14
Saint Petersburg 14
Shanghai 14
Jakarta 13
Redwood City 13
Tianjin 13
Chicago 12
Modena 12
Nanchang 12
Warsaw 11
Des Moines 10
Falkenstein 10
Forlì 10
Hải Dương 10
Jinan 10
Mumbai 10
Toronto 10
Wuhan 10
Florence 9
San Francisco 9
Bắc Giang 8
London 8
Medford 8
Paris 8
Pune 8
Quận Một 8
São Paulo 8
Totale 6.869
Salva come PNG Salva come JPEG
Nome #
Inhibition of microglia over-activation restores neuronal survival and maturation in a mouse model of CDKL5 deficiency disorder 387
Age-related cognitive and motor decline in a mouse model of CDKL5 deficiency disorder is associated with increased neuronal senescence and death 339
CDKL5 protein substitution therapy rescues neurological phenotypes of a mouse model of CDKL5 disorder 333
Beneficial Antioxidant Effects of Coenzyme Q10 in In Vitro and In Vivo Models of CDKL5 Deficiency Disorder 324
First in Class Dual Non-ATP-Competitive Glycogen Synthase Kinase 3β/Histone Deacetylase Inhibitors as a Potential Therapeutic to Treat Alzheimer’s Disease 289
Luteolin Treatment Ameliorates Brain Development and Behavioral Performance in a Mouse Model of CDKL5 Deficiency Disorder 288
Cardiac Functional and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency Disorder 284
A GABAB receptor antagonist rescues functional and structural impairments in the perirhinal cortex of a mouse model of CDKL5 deficiency disorder 282
Functional impairments in the perirhinal cortex of a mouse model of CDKL5 deficiency disorder are ameliorated by a GABAB receptor antagonist 269
AR-A014418-based dual Glycogen Synthase Kinase 3β/Histone Deacetylase inhibitors as potential therapeutics for Alzheimer's disease 263
Heterozygous CDKL5 Knockout Female Mice Are a Valuable Animal Model for CDKL5 Disorder 248
Expression of a Secretable, Cell-Penetrating CDKL5 Protein Enhances the Efficacy of Gene Therapy for CDKL5 Deficiency Disorder 247
CDKL5 deficiency predisposes neurons to cell death through the deregulation of SMAD3 signaling (vol 29, pg 658, 2019) 247
Artificial protein and its applications 242
Inhibition of microglia overactivation restores neuronal survival in a mouse model of CDKL5 deficiency disorder 240
The C-Terminal Domain of CENP-C Displays Multiple and Critical Functions for Mammalian Centromere Formation. 237
Treatment with a GSK-3β/HDAC Dual Inhibitor Restores Neuronal Survival and Maturation in an In Vitro and In Vivo Model of CDKL5 Deficiency Disorder 234
Increased DNA Damage and Apoptosis in CDKL5-Deficient Neurons 231
HDAC4: a key factor underlying brain developmental alterations in CDKL5 disorder 228
Lithium Restores Age Related Olfactory Impairment in the Ts65Dn Mouse Model of Down Syndrome 219
Age-related impairment of olfactory bulb neurogenesis in the Ts65Dn mouse model of Down syndrome 218
The amyloid precursor protein (APP) triplicated gene impairs neuronal precursor differentiation and neurite development through two different domains in the Ts65Dn mouse model for down syndrome. 213
CDKL5, a novel MYCN-repressed gene, blocks cell cycle and promotes differentiation of neuronal cells 212
Early Pharmacotherapy with Fluoxetine Rescues Dendritic Pathology in the Ts65Dn Mouse Model of Down Syndrome 211
Treatment with the GSK3-beta inhibitor Tideglusib improves hippocampal development and memory performance in juvenile, but not adult, Cdkl5 knockout mice 206
APP-dependent alteration of GSK3β activity impairs neurogenesis in the Ts65Dn mouse model of Down syndrome. 205
Functional and structural impairments in the perirhinal cortex of a mouse model of CDKL5 deficiency disorder are rescued by a TrkB agonist 205
Inhibition of GSK3β rescues hippocampal development and learning in a mouse model of CDKL5 disorder 202
Pharmacotherapy with sertraline rescues brain development and behavior in a mouse model of CDKL5 deficiency disorder 200
Functional cooperation between TrkA and p75NTR accelerates neuronal differentiation by increased transcription of GAP-43 and p21(CIP/WAF) genes via ERK1/2 and AP-1 activities 199
APP-dependent up-regulation of Ptch1 underlies proliferation impairment of neural precursors in Down syndrome. 198
Early-onset brain alterations during postnatal development in a mouse model of CDKL5 deficiency disorder 195
Voluntary Running Improves Behavioral and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency Disorder 185
Inhibition of APP gamma-secretase restores Sonic Hedgehog signaling and neurogenesis in the Ts65Dn mouse model of Down syndrome 182
Early Pharmacotherapy Restores Neurogenesis and Cognitive Performance in the Ts65Dn Mouse Model for Down Syndrome 181
DNMT3B interacts with constitutive centromere protein CENP-C to modulate DNA methylation and the histone code at centromeric regions 175
Loss of CDKL5 impairs survival and dendritic growth of newborn neurons by altering AKT/GSK-3β signaling. 175
Early-occurring proliferation defects in peripheral tissues of the Ts65Dn mouse model of Down syndrome are associated with patched1 over expression 167
CB1 cannabinoid receptors increase neuronal precursor proliferation through AKT/GSK-3{beta}/{beta}-catenin signaling 157
CENP-C binds the alpha-satellite DNA in vivo at specific centromere domains 156
Lot1 is a key element of the pituitary adenylate cyclase-activating polypeptide (PACAP)/cyclic AMP pathway that negatively regulates neuronal precursor proliferation. 146
Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome 144
null 130
Effects of a ciliary neurotrophic factor (CNTF) small-molecule peptide mimetic in an in vitro and in vivo model of CDKL5 deficiency disorder 124
Design, synthesis and pharmacological evaluation of multitarget GPR40 agonists/HDAC6 inhibitors for Alzheimer's disease 118
Heterozygous CDKL5 Knockout Female Mice Are a Valuable Animal Model for CDKL5 Disorder 112
In vivo functional dissection of human inner kinetochore protein CENP-C 109
null 101
Adult-Onset Deletion of CDKL5 in Forebrain Glutamatergic Neurons Impairs Synaptic Integrity and Behavior in Mice 94
Therapeutic efficacy of the BKCa channel opener chlorzoxazone in a mouse model of Fragile X syndrome 89
Safety and efficacy of Igk-TATk-CDKL5 gene therapy in mosaic CDKL5 deficiency 65
A cross-correction gene therapy approach for CDKL5 deficiency disorder improves the pathological phenotype of CDD patient-derived cortical organoids 41
Totale 10.546
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.900
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.900
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021319 0 0 0 0 0 0 0 0 0 48 24 247
2021/2022926 62 45 73 70 86 56 42 57 44 78 166 147
2022/20231.420 111 227 74 168 120 122 38 81 228 33 110 108
2023/2024552 27 40 23 55 28 100 71 62 44 23 28 51
2024/20251.653 104 165 141 144 208 93 100 58 80 168 109 283
2025/20264.078 394 626 347 299 468 196 547 178 794 229 0 0
Totale 10.546